Clinical trial · Observational
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District - Observational Study With Retrospective and Prospective Phase
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms. The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rare Malignant Neoplasm | Rare Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| diagnosis, surgery, drugs for rare neoplasms | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Incidence of different malignant rare neoplasms
- timeFrame
- Throughout the lenght of study, an average of 10 years
- description
- Description of types of tumours
Secondary outcomes (4)
- measure
- Response rate (RR)
- timeFrame
- Throughout the lenght of study, an average of 10 years
- description
- Response rate to different treatments (surgery, drugs)
- measure
- Local recurrence rate
- timeFrame
- Throughout the lenght of study, an average of 10 years
- description
- Incidence of local recurrence
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with histologic diagnosis of rare or highly complex malignant neoplasm * informed consent Exclusion Criteria: * none
References
Publications (0)
Data not yet available